Instrument Inactif

Communiqués Santarus, Inc.

Actions

US8028173040

Produits pharmaceutiques

Cours en clôture Nasdaq
- ^USD	-

Communiqués

31/12/13	Santarus, Inc. : Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera	PR
30/12/13	Santarus, Inc. : Santarus Announces Availability of Amended Tender Offer Materials	BU
23/12/13	Santarus, Inc. : Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis	BU
11/11/13	Santarus, Inc. : Morgan & Morgan Announces the Investigation of Santarus, Inc.	PR
11/11/13	Santarus, Inc. : Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc.	PR
08/11/13	Santarus, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders	BU
08/11/13	Santarus, Inc. : Law Offices of Howard G. Smith Announces Investigation of Santarus Inc.	BU
08/11/13	Santarus, Inc. : Investor Alert: Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of Santarus, Inc.	BU
08/11/13	Santarus, Inc. : Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal	BU
08/11/13	Santarus, Inc. : Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd.	BU
08/11/13	Santarus, Inc. : Law Firm Brower Piven Announces Investigation of Santarus, Inc. Proposed Buyout	BU
08/11/13	Santarus, Inc. : LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with Sale of the Company to Salix Pharmaceuticals, Ltd.	BU
08/11/13	Santarus, Inc. : Santarus and Pharming Announce New Data from Open-Label Repeat Treatment Study with RUCONEST (Recombinant Human C1 Esterase Inhibitor)	PU
08/11/13	Santarus, Inc. : LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company In Connection With Sale Of the Company to Salix Pharmaceuticals, Ltd.	BU
07/11/13	Santarus, Inc. : Investor Alert - Buyout Of Santarus - Shareholder Rights Law Firm Seeks Higher Price For Santarus Shareholders	PR
07/11/13	Santarus, Inc. : Santarus Reports Third Quarter 2013 Financial Results	BU
07/11/13	Santarus, Inc. : Salix Pharmaceuticals to Acquire Santarus	BU
01/11/13	Santarus, Inc. : Acquisitions, Financial Results, Clinical Trial Applications, and Upcoming Earnings Schedules - Research Report on Illumina, DENTSPLY, Alnylam, Sirona, and Santarus	PR
28/10/13	Santarus, Inc. : Santarus to Hold Third Quarter 2013 Financial Results Conference Call on November 7	BU
25/10/13	Santarus, Inc. : Santarus Announces Presentation of SAN-300 Phase I Data at 2013 American College of Rheumatology Annual Meeting	BU
04/10/13	Santarus, Inc. : Santarus Announces Presentation of Phase III Data for Rifamycin SV MMX in Travelers' Diarrhea	BU
12/09/13	Santarus, Inc. : Pre-Market Review: Isis Pharmaceuticals Inc., Community Health Systems Inc., Quest Diagnostics Inc., and Santarus Inc.	PR
03/09/13	Santarus, Inc. : Santarus to Present at September Investment Conferences	BU
07/08/13	Santarus, Inc. : Pre-Market Analysis: Community Health Systems, Isis Pharmaceuticals, Quest Diagnostics, and Santarus Inc.	PR
06/08/13	Santarus, Inc. : Santarus Reports Second Quarter 2013 Financial Results	BU